/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

U

Ulf Henrik Mellqvist

Södra Älvsborg Hospital(SE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

11

Papers

348

Citations

5

h-index

5

i10-index

Ulf Henrik Mellqvist is an academic researcher from Södra Älvsborg Hospital. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Treatment and Pharmacology. The author has an h-index of 5, co-authored 10 publications.

Research Topics

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Cancer Treatment and Pharmacology Peptidase Inhibition and Analysis Malaria Research and Control

Papers by this author

works

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial

2022 · Blood Cancer Journal · 19 citations

https://doi.org/10.1038/s41408-021-00593-2

Meletios Α. Dimopoulos Fredrik Schjesvold Vadim Doronin Olga Vinogradova

Research topics

topics

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Cancer Treatment and Pharmacology

Peptidase Inhibition and Analysis

Malaria Research and Control

Chat about Author

Papers

Chat

Click to start Chat